L B Marks. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Carcinoma, Transitional Cell/pathologyCarcinoma, Transitional Cell/radiotherapyHumansRadiotherapy DosageTime FactorsUrinary Bladder Neoplasms/pathologyUrinary Bladder Neoplasms/radiotherapy
Year: 1992 PMID: 1609133 DOI: 10.1016/s0167-8140(92)80134-5
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280